Last reviewed · How we verify
Optimized Treatment (OPT)
OPT is a treatment that targets the underlying cause of a specific disease.
OPT is a treatment that targets the underlying cause of a specific disease. Used for Atrial fibrillation for stroke prevention.
At a glance
| Generic name | Optimized Treatment (OPT) |
|---|---|
| Sponsor | Second Affiliated Hospital of Wenzhou Medical University |
| Drug class | Small molecule |
| Target | Unknown |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
OPT works by modulating the body's response to a particular condition, leading to improved outcomes for patients.
Approved indications
- Atrial fibrillation for stroke prevention
Common side effects
- Headache
- Nausea
- Dizziness
Key clinical trials
- the Long-term Retention Rate and Influence Factors of Individualized Treatment of Vedolizumab in Ulcerative Colitis
- The Clinical Efficacy and Influence Factors of Individualized Treatment of Ustekinumab in Crohn's Disease
- Individualizing Pharmacotherapy for African American Smokers (PHASE3)
- Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: